Clinical Trial Detail

NCT ID NCT03349281
Title Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Julio Barredo
Indications

lymphoblastic lymphoma

acute lymphoblastic leukemia

Therapies

Dexamethasone + Doxorubicin + MLN4924 + Pegaspargase + Vincristine Sulfate

Age Groups: child adult

No variant requirements are available.